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Abstract Primary endocrine therapy (PET) as an alternative
to surgery is widely used in the UK for the treatment of older
women with operable breast cancer. For women over 70 it has
equivalent overall survival to surgery, although local control
rates may be inferior. There are trade-offs to be made in
deciding between surgery and PET. There has been little
research to investigate the information needs of older women
or the involvement in decisionmaking they wish to have when
faced with this breast-cancer treatment decision. This review
examines the information needs of older women (>65 years)
regarding the use of surgery or PET for treating operable
primary breast cancer, and identifies their preferred format
and media for the presentation of this information. The pref-
erence for involvement in treatment decision-making among
this group will also be considered.
Keywords Breast cancer . Older women . Primary endocrine
therapy .Breast surgery . Informationneeds .Decisionmaking
preferences . Benefits . Risks .Media . Presentation . Format
Introduction
Breast cancer affects 13,000 UK women over age 70
annually, and causes the deaths of 6733 per year [1].
Among patients over 70 years of age there has been
less than half the reduction in cancer mortality achieved
for younger women [2]. This is partly caused by vari-
ance in treatment, resulting from concerns about re-
duced treatment tolerance secondary to frailty and co-
morbidity. As a result older women may not receive
chemotherapy, trastuzumab, radiotherapy, or surgery, in-
stead being offered primary endocrine therapy (PET),
which is treatment with antioestrogen tablets alone and
omitting surgery altogether. PET may be an appropriate
alternative to surgery for frail women and has equiva-
lent overall survival to surgery (plus adjuvant endocrine
therapy), although local disease control is inferior [3].
The choice of surgery or PET is complex. Both options are
associated with advantages and disadvantages, which may
vary according to health status. Surgery provides greater cer-
tainty of local cancer control but is associated with pain,
temporary hospitalisation, anaesthetic risks, and a variable
degree of disfigurement depending on the type of surgery.
PET may be associated with a higher risk of late local disease
progression, but enables avoidance of anaesthesia and surgery
(whichmay bemastectomy or wide local excision and axillary
surgery). Some older women prefer less aggressive treatments
which may enable them to maintain independence and mini-
mise potential adverse events [4, 5]. In effect, by choosing
PETan older woman is trading off the risk that she may die of
non-breast-cancer-related illness before her cancer becomes
resistant to the anti-oestrogen treatment: this is a very difficult
concept to discuss from the perspective of both the physician
and the patient herself, although many older women have a
very pragmatic acceptance of the inevitability of illness and
death [6]. Only preliminary information on older women’s
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views towards PETor surgery exists, and this subject therefore
requires further investigation [6].
At present, little is known about the information needs of
older women diagnosed with breast cancer and their personal
preferences for engagement in cancer-treatment decision mak-
ing. Such information, and the production of evidence-based
guidance, is needed to optimise the treatment of older women.
The purpose of this review is:
1. to investigate the information needs of older women
(>65 years) regarding the use of surgery or primary en-
docrine therapy (PET) for the treatment of operable pri-
mary breast cancer;
2. to identify the preferred format and media for the presen-
tation of this information;
3. to establish the preference of older women (>65 years) for
involvement in treatment decision making regarding the
use of surgery or PET for the treatment of operable
primary breast cancer.
Methods
Search Strategy
A comprehensive search of the published literature was un-
dertaken during July 2013, using the following electronic
databases:
& MEDLINE
& PsycINFO
& CINAHL
& Scopus
& Web of Science
& The Cochrane Library
Three searches were performed, using the search terms
below. Controlled vocabulary terms were used where
available.
1. “older women” + “breast cancer” + “PET” “Surgery”
“information needs”
2. “older women” + “cancer” + “information needs” review
articles.
3. “older people” + “cancer” + “information needs”
Limits placed on the search were:
& Date: 1980–present day, (PET was introduced during the
early 1980s).
& Participants: Humans, Females.
& Language: English.
Inclusion Criteria
Articles were deemed to meet the inclusion criteria if:
1. They included patients with a diagnosis of breast cancer;
2. They included women over 65 years (65 is a definition of
older in the UK and USA);
3. They included patients treated with surgery, primary endo-
crine therapy (PET), chemotherapy, and/or radiotherapy; and
4. The focus was on information needs and/or preferred
media and format of information and/or preference for
decision making.
Exclusion Criteria
Articles were excluded from the review if:
1. None of the participants in the mixed cancer studies were
over 65 years of age;
2. They only assessed clinical effectiveness or outcome of
PET or surgery;
3. They were not in the English language.
Results of the Search
On completion of the searches, titles of papers and (where
available) abstracts were scrutinised for possible inclusion in
the review by one researcher (MB), and these inclusions were
checked for accuracy by the second researcher (KC). Uncer-
tainties were resolved through discussion. A total of 9767
papers were identified from the three searches.
To reduce the number of results generated from the
searches, a decision was taken by the study team to focus
exclusively on studies where the study sample was exclusive-
ly “breast cancer” or where the study sample was a mixed
cohort but included patients with “breast cancer”.
This left 3190 papers. After removal of ineligible and
duplicate abstracts, 275 titles from searches 1 and 2 were
deemed potentially eligible and the abstracts were retrieved.
From the abstracts 122 papers were potentially eligible and so
the full article was reviewed.
Studies that focused solely on psychosocial needs, quality
of life after treatment, decision-making styles, clinical out-
come of surgery, or the function of health-care professionals
(HCPs) in decision making were excluded. This resulted in 77
papers fulfilling the inclusion criteria and being included
within the review. See Fig. 1.
Two of these papers were systematic reviews of older
cancer patients, one focusing on unmet support needs of
newly diagnosed patients and one focused on information
needs regarding cancer, the treatment available, and the
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preference for involvement in decision making. Thirty-eight
papers were breast-cancer studies of mixed-age cohorts which
included a proportion of women 65 and older. A further 17
papers were cancer studies (including breast cancer) of mixed-
age cohorts including a proportion of those 65 and older. Only
six papers included only those aged 65 and older. Two papers
focused predominantly on treatment decision making for
breast cancer, and two on the information needs and two on
the experiences of women with breast cancer. Only one of
these papers investigated patient views on their experience of
PETor surgery. Of the six papers identified, only one was UK-
based. The remaining five were from Canada and the USA.
See Table 1 for summary of these papers.
Literature Review
Information Needs of Older Women
The results below are based on all 77 reviewed articles. All
papers reviewed investigated, either in whole or in part, the
information needs of older patients with breast cancer. See
Table 2 for a summary of identified information needs.
Clinical and Treatment Information
At diagnosis, receiving information about the chance of a cure
and the spread of the disease were the most commonly
reported concerns of most patients [7–11, 12•, 13], regardless
of age. The need for medical information about the disease,
the nature of breast cancer, the symptoms, the diagnostic tests,
the treatment options, and prognosis were also reported to be
important for older women (>70 years) with breast cancer [14,
15•, 16].
Within the identified papers, older women had a greater
desire than younger women to receive information on the
effect of treatment on their functional independence, self-
care, quality of life [6, 8, 17, 18], and social life [19, 20].
The effect of treatment on physical appearance or surgical
disfigurement and sexual attractiveness were reported by
some studies to be more important to younger women [8,
12•, 20], although other studies did not support this view
[21, 22].
Information on the practical aspects of treatment was also
important to older cancer patients [15•, 23–25]. Difficulties of
driving or transport, particularly in winter, ease and cost of
parking [9, 15•], dates and times of surgery, or the timing of
test results [29] were more of a concern to older patients than
the treatment itself [9, 15•]. For some older patients, such
factors influenced their final treatment decision [18].
Treatment Decision Making for Older Patients
Providing treatment choice to patients presents a considerable
decision-making challenge. For the older person diagnosed
with cancer, it requires that they consider their own health,
functional and social status, and values about quality or
Arcles idenﬁed through 
database searching 
(n = 3190 )
Addional arcles idenﬁed 
through other sources
(n = 4 )
Arcles aer duplicates removed:
(n = 2691)
Arcles  screened:
(n = 275)
Arcles excluded:
(n = 2416)
Full-text arcles assessed 
for eligibility 
(n =  122 )
Full-text arcles 
excluded, 
(n = 45)
Arcles  included in 
review
(n = 77 )
Fig. 1 Flow chart of review
process
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quantity of life [27]. Extrinsic factors including the informa-
tion received and the opinions of health-care professionals and
family and friends all contribute to the decision-making pro-
cess. There is evidence that patient involvement in treatment
decision making usually increases treatment satisfaction and
reduces anxiety and depression [28–31]. Three main patient
decision-making styles have been described: active, those
who wish to make their own healthcare decisions; collabora-
tive, those who wish to share decision making; and passive,
those who defer decision making to others [32]. Breast-cancer
patients generally (not specifically older women) increasingly
prefer more active and collaborative roles in treatment deci-
sion making [32, 33], although some prefer to defer decisions
to others [28, 29, 34, 35]. A recent UK study reported the
preferred decision making styles of women with breast cancer
Table 2 Summary of findings
Information desired on disease and treatment
Chances of cure, spread, or recurrence of disease, and prognosis
Understanding the diagnosis and the rationale for treatment
Recommended treatment plan
Effectiveness and side effects of treatment options
How to avoid and relieve side effects
Effect of treatment on self-care, independence, and social life
Effect of treatment on emotional wellbeing and psychosocial aspects
Practical information, e.g. transport, important in deciding on treatment
The level and amount of information
Preference for amount of information highly variable
Information provision to be tailored to the individual’s situation and
preferences
Limited need for large volumes of general information
Personal stories of others in similar circumstances are appreciated by
some
Receiving information
Simple booklets, jargon-free language, and simple diagrams are preferred
Preference of words to numbers to describe or quantify risk
Verbal information preferred, preferably from the treating clinician
Time given during consultation to ask questions
Information provision needs to change over the treatment pathway
Sources of information
Health-care professionals believed best source of information
Written information poorly used
Family and friends a further source of information for some
The internet used by a minority to find health information
Decision making
Patients may want to play an active part in the decision-making process
With increasing age there is a trend towards relying on the surgeon for the
decision
Not all older breast-cancer patients want a passive role
Patient preference for decision making should be investigated
Older breast-cancer patients frequently make decisions on the basis of
limited, inaccurate knowledge
T
ab
le
1
(c
on
tin
ue
d)
A
ut
ho
r
C
ou
nt
ry
of
st
ud
y
O
bj
ec
tiv
es
of
st
ud
y
St
ud
y
m
et
ho
ds
,s
am
pl
e
an
d
ag
e
ra
ng
e
K
ey
fi
nd
in
gs
in
di
ca
te
d
ad
ju
va
nt
no
n-
ho
rm
on
al
ch
em
ot
he
ra
py
50
/5
0
sp
lit
be
tw
ee
n
th
os
e
w
ho
ha
d
ch
em
ot
he
ra
py
an
d
th
os
e
w
ho
di
d
no
t.
pr
ac
tic
al
iti
es
w
ith
do
ct
or
an
d
fa
m
ily
;f
am
ily
to
gi
ve
em
ot
io
na
la
nd
de
ci
si
on
-m
ak
in
g
su
pp
or
t
•
B
ar
ri
er
s
to
ch
em
ot
he
ra
py
up
ta
ke
:u
se
of
m
ed
ic
al
la
ng
ua
ge
;h
ur
ri
ed
ap
po
in
tm
en
ts
;t
oo
m
uc
h
ge
ne
ra
li
nf
or
m
at
io
n
no
ts
pe
ci
fi
c
en
ou
gh
fo
r
in
di
vi
du
al
•
C
he
m
ot
he
ra
py
of
te
n
th
ou
gh
tt
o
be
no
ta
s
ba
d
as
ex
pe
ct
ed
Sc
ho
nb
er
g
M
A
et
al
.(
20
12
)
U
S
A
To
id
en
tif
y
fa
ct
or
s
th
at
in
fl
ue
nc
e
th
e
br
ea
st
-c
an
ce
r
tr
ea
tm
en
td
ec
is
io
ns
of
w
om
en
ag
ed
80
an
d
ol
de
r
M
ed
ic
al
no
te
re
vi
ew
.
65
w
om
en
ag
ed
80
an
d
ol
de
r.
A
ge
ra
ng
e
80
–8
6
ye
ar
s.
M
ed
ia
n
ag
e
84
ye
ar
s
•
Fa
ct
or
s
w
hi
ch
in
fl
ue
nc
e
w
om
en
in
cl
ud
ed
:f
am
ily
in
vo
lv
em
en
t,
si
de
ef
fe
ct
s,
re
lig
io
us
be
lie
f,
pr
ev
io
us
ex
pe
ri
en
ce
of
ca
nc
er
tr
ea
tm
en
te
ff
ic
ac
y,
ph
ys
ic
ia
n’
s
op
in
io
n
•
10
/6
5
w
om
en
in
iti
al
ly
di
d
no
tw
an
ta
gg
re
ss
iv
e
tr
ea
tm
en
tb
ut
ag
re
ed
to
it
af
te
r
di
sc
us
si
on
w
ith
ph
ys
ic
ia
n
•
2/
65
w
om
en
w
an
te
d
as
ag
gr
es
si
ve
a
tr
ea
tm
en
t
as
po
ss
ib
le
fr
om
th
e
ou
ts
et
Curr Breast Cancer Rep
FO
R 
AP
PR
OV
AL
 
by mean age. Those who preferred an active role were on
average 57.4 years, those preferring a collaborative role were
on average 58.4 years, and those preferring a passive role were
on average 61.1 years; less than 20 % of women preferred to
defer their treatment decision to others. However, the average
age of participants in this study was much younger than 70
(mean age 58.5, with only 10.7 % over 70 years) and the
results may therefore be irrelevant to this older age group [32].
There is limited evidence on which to assess the
preferences for treatment decision making of older
women with breast cancer; however, the evidence sug-
gests that older patients are more passive in their deci-
sion making than their younger counterparts [6, 13, 32,
36, 37]. Breast-cancer patients, regardless of age, fre-
quently consult family and friends, who provide anec-
dotal and possibly erroneous information [38], and tend
to delegate responsibility for decisions to their doctors,
family, and friends [5, 38–40]. Personal experience of
others’ cancer is also a factor which affects knowledge
of cancer treatments [6]. There is unclear evidence on
the use of other media, including newspaper and televi-
sion, in information seeking and decision making. Mills
and Davidson [41] found that television and radio are
infrequently used by those over 65 years, but Hughes
[42] reported that lay media may be one of the top
three sources for information. Talosig-Garcia and Davis
[43] found newspapers and magazines to be a very
helpful source of information for women.
An American study of 1131 patients with breast cancer, of
whom 249 were over 70, revealed a high level of involvement
in treatment decision making (52 %), with approximately half
the women stating that they had the right amount of involve-
ment [44]. However, over 40 % felt they had too much
involvement and a small percentage felt they had too little
involvement (7.6 %). Overall the researchers concluded that
involvement did not vary with age but there was a trend for
less involvement with increasing age. This conclusion was
supported by Han et al. [45].
A study of healthy individuals concluded that most women
prefer clinical decisions to be taken by their doctor, and that
past the age of 45 the desire for participation in treatment
decision making decreased [46].
Patients may want to be fully informed and partici-
pate in the decision-making process by making their
preferences, values, opinions, and fears known regard-
less of age [18, 22, 23, 47, 48]. However, there is a
trend for older patients to prefer the surgeon to make
the final treatment decision [11, 20, 22, 45, 49], and
this seems to be related to the severity of their illness
[50]. Where best practice is known, surgeons are confi-
dent in recommending a particular intervention; howev-
er, where best practice is unclear surgeons more fre-
quently invite the patient to choose [26].
Factors Affecting Treatment Choice
Only one study [6] was identified that examined the factors
affecting the treatment decisions of older women faced with a
choice of surgery or PET for the treatment of breast cancer. In
this study 21 purposively selected breast-cancer patients, who
had been treated with either PET or surgery, took part in in-
depth qualitative interviews. This study found that the women
relied heavily on health-care providers for information; how-
ever, this information was not used to make the treatment
decision. Women were reported to be listening for cues from
the medical team to detect what was being recommended. In
line with other studies, the women did not actively question
the information given to them by the doctor. A small number
of women actively chose treatment contrary to the advice of
the medical team, and their decision was on the basis of family
experience of breast cancer. Avoidance of surgery was not a
factor for women choosing PET; however, previous painful
biopsies were a consideration.
Amount and Level of Information
Patients with cancer have high information needs and the
same is true for breast cancer, irrespective of patient age
[51–53, Caldon L, PhD thesis 2011 “Patient and Clinician
factors influencing the choice of breast cancer surgery: a
qualitative and quantitative study”, unpublished data]. Infor-
mation is a pre-requisite for informed decision making [34,
51, 54]. The type, amount, and level of information preferred
differs across the treatment pathway and between individuals
[16], and the amount of information collected does not always
correlate with the desire to make decisions [4, 17, 49, 55] or
with the patient’s preferred decision-making style [7, 22, 34,
55]. The amount of information older patients require to make
a treatment decision is variable [56]. Some older patients find
the type and amount of medical information they receive
overwhelming [23], and they have fewer information needs
[19]. Others want as much information as possible to help
them better understand their treatment options and the ratio-
nale for treatment [15, 26]. Other studies report older patients
having a lower need for information [11, 12•, 14], with a meta-
analysis revealing a trend towards younger patients preferring
a more active decision-making role and having a greater need
for information [57]. In contrast, Cox et al. [22] found little or
no difference in the need for information between younger and
older patients. Several authors have concluded that informa-
tion about breast-cancer treatment options needs to be age
specific, relevant, and tailored to the patient [15, 23, 47, 58].
Older women rely primarily on the information given by
their clinician or breast-care nurse, and subsequently on infor-
mation given by their family, to make decisions about their
treatment [6, 48, 59, 60]. Older women are also less likely than
their younger counterparts to question their clinician to gain
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further information regarding different treatment options [5].
However, given adequate time during the consultation older
patients do seem to seek more detailed information about their
condition [59–61]. Older women require information that is
simple, balanced, and in sufficient detail to enable them to
reach an informed decision independently [15•]. Specific in-
formation regarding age-specific incidence, risk factors for
breast cancer in older age, signs and symptoms of breast
cancer, breast-cancer treatment options, and age-specific prog-
nostic information was most highly regarded [15•].
Pacing of Information
Older cancer patients prefer paced information which is re-
peated to allow time for assimilation [22], with information
provided throughout the treatment pathway as information
needs change [14]. Patients’ recall is impaired in life-
threatening situations [42, 62], and information absorption is
hindered when individuals are provided with information they
find difficult or unpleasant [62] or when they are
overwhelmed by the provision of excessive information in a
single consultation [64]. Patients’ recall is better for informa-
tion provided at the start of a consultation [64]. Despite
barriers, for example to the patient’s ability to absorb and
recall information when confronted by a diagnosis of cancer,
the information that is recalled can persist and gain importance
over time, with older patients quoting their clinicians verbatim
[63]. Fallowfield et al. [64] proposed that “…information
needs to be given systematically, at the right time and via
several different routes, to maximise the chances for patients
to understand the implications and make really informed
choices” [65].
Preferences for Format and Media of Information
Older patients prefer information to be given to them verbally
by their treating clinician [51, 53, 65]. However, study find-
ings consistently suggest that clinicians often underestimate
patients’ information needs [8, 66–69]. A recent study of the
use of information technology found that only 15% of the UK
population of older people (i.e. those aged 60 and older) had
access to a computer. Use of the internet remains low, with
only 14 % of adults over 70 years using it for seeking health
information [70]. Couper et al. [71] reported that older people
(aged over 70) tended to use their computer for word process-
ing and not as a source of information for such complex
subjects as breast cancer. Those who did use the internet either
rated the information highly but only as a supplement to that
provided by the health-care provider, or reported that they
struggled with the volume of information and knowing how
to assess its credibility [15•]. In summary, the internet has
been revealed to be rarely used by the older population to
access breast-cancer treatment information [43].
Presenting complex material to older patients who possibly
have declining cognitive function is a substantial challenge.
Although there is a correlation between comprehension and
literacy across all age groups, when compared with a younger
age group older adults have poorer numeracy and comprehen-
sion of written information [12•, 47, 70, 72–74]. Other factors,
including poor hearing and eyesight, may also affect the
ability of older patients to make an informed treatment deci-
sion [74, 75].
When people have little or no understanding of the choices
being presented, it is difficult for them to have any real
understanding of the consequences of a choice and what effect
it would have on their lives. The use of narratives or stories
has been revealed to enhance the ability to assess attributes
and weigh them in decision making. Where tables and graphs
were used, older breast-cancer patients needed an explanation
of the data in order for it to have meaning to them [74] and for
them to make a better judgement regarding a treatment choice
[73, 76, 77]. The provision of personal cancer stories within
the information was also regarded as useful in helping them
understand and cope with the disease and its treatment [15•,
21]. The combined use of anecdotes and pictograms was
reported to enhance understanding and decision making
among women aged under 79 years diagnosed with breast
cancer [78].
Simple booklets [50] with short explanations of risks and
benefits of treatment, free of medical language and with clear
diagrams [15•, 21], were requested by older women undergo-
ing adjuvant therapy. It was found that older women did not
respond well to complex information and that the heterogene-
ity of the population would necessitate many different
formats.
Tailoring or customising information also reduces cogni-
tive load. Stories or narratives based on the experiences of
people like themselves emphasise the meaning a choice would
have on women’s lives. This is particularly effective when the
story triggers a memory [79]. Tailored health materials are
reported to be more effective than general material at enhanc-
ing behavioural change [76]
Evidence suggests that presenting risks and benefits to
experts and the general public as frequencies rather than
probabilities is more meaningful and carries more weight in
decision making [76]. This is contrary to the findings of
Fausset and Rogers [74], who report that older people (mean
age 71, range 65–75) performed better using percentage
values than frequencies. In the Hughes study [42] of a younger
population (mean age 41, range 21–80) choice of treatment
was unrelated to the way the information was presented. There
was no difference in choice of mastectomy or breast-
conserving surgery whether description or probabilities were
used to present risk.
The framing of information provision also affects the
meaning older patients attribute to it. A review by Edwards
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et al. [80] examining the effect of framing of risk information
concluded that the evidence of the effect of framing was weak.
There was some indication of framing increasing the uptake of
detection behaviours, e.g. screening. There was also limited
evidence to suggest patients choose what might be perceived
as risky treatments when information is positively framed.
Although this review examined clinical studies the results
were not stratified by patient age.
Graham, Martin and Browne [81] studied 262 women (no
age range given) with breast cancer to identify their preference
for language, percentages, or numbers in describing the risk of
treatment. Fifty-two percent preferred language and 48 %
numerical expression (21 % numbers and 27 % percentages)
to describe risk. Those who were younger, i.e. below the mean
age of 62, and were more highly educated preferred numerical
representation. Strategies suggested included diagrams and
risk–benefit tables to aid conceptualisation. Problems around
credibility of information given and how to filter the volume
of information available were raised. Edwards et al. [80] found
no evidence of effect in the way data were presented.
Conclusions
There is a dearth of evidence on the information needs of older
women when faced with a choice of PETor surgery for early-
stage breast-cancer treatment. Similarly, there is little infor-
mation on the preferred format, presentation, or media, nor on
the preferred involvement in treatment decision making of
older women with breast cancer.
There is some agreement about the required type of infor-
mation relating to breast cancer and its treatment, and on how
this needs to be delivered across the treatment pathway. Infor-
mation on the effect of the treatment on self-care, physical
function, and quality of life seems to be universally desired by
older women.
There is limited evidence on which to assess the preference
for treatment decision making of older women with breast
cancer; however, the evidence suggests that older patients are
more passive in their decision making than their younger
counterparts [6, 32, 36, 37].
One of the objectives of providing information is to enable
women to make informed decisions about their breast-cancer
treatment. Patients may want to be fully informed and to
participate in the decision-making process by making their
preferences, values, opinions, and fears known [18, 22, 23,
47]. However, there is a trend for older patients to prefer the
surgeon to make the final treatment decision [11, 20, 22, 45,
49].
The main source of information is the health-care provider:
either the clinician or breast-care nurses. There is a preference
for personalised information received verbally. The internet is
not widely used by older patients. Written information is the
usual format preferred. Simple booklets using clear, jargon-
free language are preferred, with the addition of uncomplicat-
ed diagrams and stories of women in a similar situation. In
describing risk and benefit, there is some evidence that words
are preferred to numbers.
The evidence presented is on the basis of limited literature
and so cannot be relied upon to give an accurate or complete
picture. High-quality research is required to establish the
information needs of older women, specifically those over
70 years, their preferences regarding format and media, and
their preferred level of treatment decision making when faced
with a choice of treatment for early-stage breast cancer.
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